Allurion Technologies Inc. (ALUR) Financial Ratios
5 years of historical data (2020–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
N/A
—
5yr avg: -26.1%
30Y Low-26%·High-26%
Debt/EBITDA
N/A
—
5yr avg: 0.85
30Y Low0.8·High0.8
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ALUR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Allurion Technologies Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $2M | $24M | $133M | $272M | $13.2B | — |
| Enterprise Value | $24M | $47M | $137M | $324M | $13.2B | — |
| P/E Ratio → | -0.06 | — | — | — | — | — |
| P/S Ratio | 0.05 | 0.75 | 2.49 | 4.23 | 346.31 | — |
| P/B Ratio | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ALUR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.45 | 2.56 | 5.04 | 346.32 | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
ALUR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Allurion Technologies Inc. earns an operating margin of -156.3%. Operating margins have compressed from -49.9% to -156.3% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 67.0% | 67.0% | 77.6% | 79.0% | 76.3% | — |
| Operating Margin | -156.3% | -156.3% | -147.9% | -49.9% | -32.7% | — |
| Net Profit Margin | -81.4% | -81.4% | -150.8% | -58.8% | -32.4% | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | -26.1% |
| ROA | -50.0% | -50.0% | -131.0% | -83.2% | -62.4% | -1.6% |
| ROIC | — | — | — | -122.9% | — | — |
| ROCE | -496.1% | -496.1% | -1257.8% | — | -322.2% | -26.1% |
ALUR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $23M ($38M total debt minus $15M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 8.57 |
| Debt / EBITDA | — | — | — | — | — | 0.85 |
| Net Debt / Equity | — | — | — | — | — | 6.20 |
| Net Debt / EBITDA | — | — | — | — | — | 0.61 |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -22.17 | -22.17 | -7.48 | -7.23 | -3.41 | — |
ALUR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.44x means Allurion Technologies Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.57x to 1.44x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.44 | 1.44 | 0.99 | 0.57 | 1.18 | 0.15 |
| Quick Ratio | 1.26 | 1.26 | 0.90 | 0.52 | 1.09 | 0.15 |
| Cash Ratio | 0.82 | 0.82 | 0.58 | 0.10 | 0.82 | 0.15 |
| Asset Turnover | — | 0.98 | 0.75 | 1.25 | 0.97 | — |
| Inventory Turnover | 3.12 | 3.12 | 1.94 | 3.49 | 3.33 | — |
| Days Sales Outstanding | — | 81.09 | 124.20 | 166.81 | 65.21 | — |
ALUR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Allurion Technologies Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $2M | $1M | $1M | $54M | $108M |
Peer Comparison
Compare ALUR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ALURYou | $2M | -0.1 | — | — | 67.0% | -156.3% | — | — | — |
 GUTS | $113M | -0.4 | — | — | — | — | -744.2% | -1115.0% | — |
 NVCR | $2B | -13.5 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 INVA | $2B | 6.8 | 8.0 | 9.8 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 ELMD | $215M | 30.2 | 18.4 | 19.4 | 78.1% | 15.1% | 17.2% | 25.6% | 0.0 |
 NVO | $203B | 12.7 | 9.4 | 44.7 | 81.0% | 41.3% | 60.7% | 36.2% | 0.9 |
 LLY | $933B | 43.0 | 31.0 | 104.0 | 83.8% | 45.6% | 101.2% | 41.8% | 1.4 |
 AMGN | $179B | 23.3 | 14.1 | 22.1 | 70.8% | 29.1% | 106.1% | 14.8% | 3.4 |
 HIMS | $7B | 52.7 | 44.5 | 93.8 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 TDOC | $1B | -6.0 | 14.8 | 4.3 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 NVAX | $2B | 3.7 | 2.6 | — | 93.7% | 50.1% | — | — | 0.4 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 5 years · Updated daily
See ALUR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALUR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALUR vs GUTS
Side-by-side business, growth, and profitability comparison vs Fractyl Health, Inc. Common Stock.
Start ComparisonALUR — Frequently Asked Questions
Quick answers to the most common questions about buying ALUR stock.
What is Allurion Technologies Inc.'s P/E ratio?
Allurion Technologies Inc.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
Is ALUR stock overvalued?
Based on historical data, Allurion Technologies Inc. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Allurion Technologies Inc.'s profit margins?
Allurion Technologies Inc. has 67.0% gross margin and -156.3% operating margin.